{
  "ticker": "JNJ",
  "target_date": "2025-10-31",
  "actual_date": "2025-10-31",
  "collected_at": "2025-12-08T12:28:38.503206",
  "price": {
    "open": 186.28,
    "high": 188.3,
    "low": 185.58,
    "close": 187.6783905029297,
    "volume": 8791700,
    "change_1d_pct": -0.1,
    "change_7d_pct": -2.11,
    "change_30d_pct": 7.2
  },
  "technicals": {
    "rsi_14": 43.14,
    "sma_20": 189.3,
    "sma_50": 182.16,
    "macd": 1.572,
    "macd_signal": 2.512,
    "macd_histogram": -0.94,
    "bb_upper": 193.24,
    "bb_lower": 185.35,
    "price_vs_sma20_pct": -0.85,
    "price_vs_sma50_pct": 3.03,
    "volume_ratio": 1.06
  },
  "fundamentals": {
    "market_cap": 487641317376,
    "pe_ratio": 19.53668,
    "forward_pe": 19.094337,
    "price_to_book": 6.1432,
    "price_to_sales": 5.2918787,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.6,
    "pct_from_52w_low": 43.87
  },
  "macro": {
    "spy": {
      "price": 682.06,
      "change_1d_pct": 0.33,
      "change_7d_pct": 1.53
    },
    "vix": {
      "level": 17.44,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.1
    },
    "dollar_index": {
      "level": 99.8
    },
    "gold": {
      "price": 3982.2
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised",
      "source": "Yahoo",
      "datetime": 1761933960,
      "summary": "ABBV tops Q3 earnings and revenue estimates, driven by Rinvoq and Skyrizi gains, and lifts its 2025 EPS outlook.",
      "url": "https://finnhub.io/api/news?id=665bb54d202d0def053ba5ff679d874d43999bab51b0937b298fad08b42453f4"
    },
    {
      "headline": "Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings?",
      "source": "Yahoo",
      "datetime": 1761933600,
      "summary": "Black Diamond Therapeutics gears up for Q3 results as investors eye key silevertinib data and additional development plans.",
      "url": "https://finnhub.io/api/news?id=b279a3d0aa930026ff6987354bef78a7d4427dcabe962d3bfb098de6b8c0df1e"
    },
    {
      "headline": "Appointment of Yves Decadt as Member of Poxel\u2019s Board of Directors",
      "source": "Yahoo",
      "datetime": 1761933120,
      "summary": "LYON, France, October 31, 2025--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and ",
      "url": "https://finnhub.io/api/news?id=4cc6078451ebb4f00640bb8260e2be8234322f630fd1f7116528bb06feb75c2d"
    },
    {
      "headline": "I\u2019m 65, itching to retire but only have $500K saved. I want $2K/month plus my Social Security \u2014 how can I swing this?",
      "source": "Yahoo",
      "datetime": 1761928200,
      "summary": "Here are four options for supplementing your retirement.",
      "url": "https://finnhub.io/api/news?id=0595ce1375b38b69c1e30bb63d5d25d983409f7c20e7ae4ad763774596f2d252"
    },
    {
      "headline": "AbbVie Beats Third-Quarter Estimates. There\u2019s More to the Drugmaker\u2019s Earnings.",
      "source": "Yahoo",
      "datetime": 1761913200,
      "summary": "FEATURE   AbbVie stock traded slightly lower Friday as the biopharmaceutical giant reported mixed results across its drug portfolios in the third quarter. Adjusted earnings of $1.86 a share topped the $1.",
      "url": "https://finnhub.io/api/news?id=05775eb82c527aaf9b53fc389dbdf8ae36f1b928160854392932d9f0a156ab6b"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "10-Q",
      "date": "2025-10-22",
      "description": "jnj-20250928.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/jnj-20250928.htm"
    },
    {
      "form": "4",
      "date": "2025-10-20",
      "description": "xslF345X05/wk-form4_1761002033.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000204/xslF345X05/wk-form4_1761002033.xml"
    },
    {
      "form": "8-K",
      "date": "2025-10-14",
      "description": "jnj-20251014.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000201/jnj-20251014.htm"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627547.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000196/xslF345X05/wk-form4_1757627547.xml"
    },
    {
      "form": "4",
      "date": "2025-09-11",
      "description": "xslF345X05/wk-form4_1757627315.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000194/xslF345X05/wk-form4_1757627315.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}